BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun Y, Wu L, Zhong Y, Zhou K, Hou Y, Wang Z, Zhang Z, Xie J, Wang C, Chen D, Huang Y, Wei X, Shi Y, Zhao Z, Li Y, Guo Z, Yu Q, Xu L, Volpe G, Qiu S, Zhou J, Ward C, Sun H, Yin Y, Xu X, Wang X, Esteban MA, Yang H, Wang J, Dean M, Zhang Y, Liu S, Yang X, Fan J. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell 2021;184:404-421.e16. [PMID: 33357445 DOI: 10.1016/j.cell.2020.11.041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Deisenhammer F, Borena W, Bauer A, Kimpel J, Rudzki D, Schanda K, Egeter J, Hüfner K, Sperner-Unterweger B, Reindl M. 6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort. Wien Klin Wochenschr 2021;133:351-8. [PMID: 33315138 DOI: 10.1007/s00508-020-01795-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Brunner C, Grillet M, Urban A, Roska B, Montaldo G, Macé E. Whole-brain functional ultrasound imaging in awake head-fixed mice. Nat Protoc 2021;16:3547-71. [PMID: 34089019 DOI: 10.1038/s41596-021-00548-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Verma J, Subbarao N. A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics. Arch Virol 2021;166:697-714. [PMID: 33483791 DOI: 10.1007/s00705-021-04961-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kawabe Y, Tanaka T, Isonishi A, Nakahara K, Tatsumi K, Wanaka A. Characterization of Glial Populations in the Aging and Remyelinating Mouse Corpus Callosum. Neurochem Res 2022. [PMID: 35859078 DOI: 10.1007/s11064-022-03676-z] [Reference Citation Analysis]
5 Liu Z, Zhang S, Ouyang J, Wu D, Chen L, Zhou W, Xie L, Zhang Y. Single-Cell RNA-seq Analysis Reveals Dysregulated Cell-Cell Interactions in a Tumor Microenvironment Related to HCC Development. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/4971621] [Reference Citation Analysis]
6 Bai R, Cui J. Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing. Front Immunol 2022;13:890166. [DOI: 10.3389/fimmu.2022.890166] [Reference Citation Analysis]
7 Ma RY, Black A, Qian BZ. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol 2022;43:546-63. [PMID: 35690521 DOI: 10.1016/j.it.2022.04.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chen C, Liu J, Chen Y, Lin A, Mou W, Zhu L, Yang T, Cheng Q, Zhang J, Luo P. Application of ATAC-seq in tumor-specific T cell exhaustion. Cancer Gene Ther. [DOI: 10.1038/s41417-022-00495-w] [Reference Citation Analysis]
9 Li XY, Shen Y, Zhang L, Guo X, Wu J. Understanding initiation and progression of hepatocellular carcinoma through single cell sequencing. Biochim Biophys Acta Rev Cancer 2022;:188720. [PMID: 35304295 DOI: 10.1016/j.bbcan.2022.188720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhao Q, Wang Q, Wang T, Xu J, Li T, Liu Q, Yao Q, Wang P. Pattern Recognition Receptors (PRRs) in Macrophages Possess Prognosis and Immunotherapy Potential for Melanoma. Front Immunol 2021;12:765615. [PMID: 34858419 DOI: 10.3389/fimmu.2021.765615] [Reference Citation Analysis]
11 Zhang L. Single-Cell Profiling Explore the Immunologic Mechanisms of Tumor Relapse in Hepatocellular Carcinoma. Glob Med Genet 2021;8:83-4. [PMID: 34430957 DOI: 10.1055/s-0041-1729545] [Reference Citation Analysis]
12 Wang H, Yu S, Cai Q, Ma D, Yang L, Zhao J, Jiang L, Zhang X, Yu Z. The Prognostic Model Based on Tumor Cell Evolution Trajectory Reveals a Different Risk Group of Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:737723. [PMID: 34660596 DOI: 10.3389/fcell.2021.737723] [Reference Citation Analysis]
13 Hindson J. Single-cell RNA sequencing of early-relapse hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2021;18:150. [PMID: 33594272 DOI: 10.1038/s41575-021-00428-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Barcena-Varela M, Lujambio A. The Endless Sources of Hepatocellular Carcinoma Heterogeneity. Cancers (Basel) 2021;13:2621. [PMID: 34073538 DOI: 10.3390/cancers13112621] [Reference Citation Analysis]
15 Su S, Du L, Jiang S. Learning from the past: development of safe and effective COVID-19 vaccines. Nat Rev Microbiol 2021;19:211-9. [PMID: 33067570 DOI: 10.1038/s41579-020-00462-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 17.0] [Reference Citation Analysis]
16 Liu Y, Zou L, Tang H, Li J, Liu H, Jiang X, Jiang B, Dong Z, Fu W. Single-Cell Sequencing of Immune Cells in Human Aortic Dissection Tissue Provides Insights Into Immune Cell Heterogeneity. Front Cardiovasc Med 2022;9:791875. [DOI: 10.3389/fcvm.2022.791875] [Reference Citation Analysis]
17 Guo Y, Ren Y, Chen L, Sun T, Zhang W, Sun B, Zhu L, Xiong F, Zheng C. Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma. BMC Cancer 2022;22:270. [PMID: 35287627 DOI: 10.1186/s12885-022-09325-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sun BY, Zhou C, Guan RY, Liu G, Yang ZF, Wang ZT, Gan W, Zhou J, Fan J, Yi Y, Qiu SJ. Dissecting Intra-Tumoral Changes Following Immune Checkpoint Blockades in Intrahepatic Cholangiocarcinoma via Single-Cell Analysis. Front Immunol 2022;13:871769. [PMID: 35558087 DOI: 10.3389/fimmu.2022.871769] [Reference Citation Analysis]
19 Fu J, Cao Z, Zhang J, Chen Q, Wang Y, Wang S, Fang X, Xu X. Identification of two immune-related risk score signatures through integrated analysis of multi-omics data in hepatocellular carcinoma. Gene 2022;829:146519. [PMID: 35447248 DOI: 10.1016/j.gene.2022.146519] [Reference Citation Analysis]
20 Li X, Ramadori P, Pfister D, Seehawer M, Zender L, Heikenwalder M. The immunological and metabolic landscape in primary and metastatic liver cancer. Nat Rev Cancer 2021;21:541-57. [PMID: 34326518 DOI: 10.1038/s41568-021-00383-9] [Reference Citation Analysis]
21 Tan Y, Xu Q, Wu Z, Zhang W, Li B, Zhang B, Xu X, Zhang B, Yan K, Song J, Lv T, Yang J, Jiang L, Shi Y, Yang J, Yan L. Overexpression of PD-L1 is an Independent Predictor for Recurrence in HCC Patients Who Receive Sorafenib Treatment After Surgical Resection. Front Oncol 2022;11:783335. [DOI: 10.3389/fonc.2021.783335] [Reference Citation Analysis]
22 Liu Z, Gao Z, Li B, Li J, Ou Y, Yu X, Zhang Z, Liu S, Fu X, Jin H, Wu J, Sun S, Sun S, Wu Q. Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression. Oncoimmunology 2022;11:2085432. [PMID: 35712121 DOI: 10.1080/2162402X.2022.2085432] [Reference Citation Analysis]
23 Lin P, Gao RZ, Wen R, He Y, Yang H. DNA Damage Repair Profiles Alteration Characterize a Hepatocellular Carcinoma Subtype With Unique Molecular and Clinicopathologic Features. Front Immunol 2021;12:715460. [PMID: 34456923 DOI: 10.3389/fimmu.2021.715460] [Reference Citation Analysis]
24 Fang H, Zeng Y, Zhang L, Chen C, Powell CA, Wang X. Can single‐cell RNA sequencing reshape the clinical biochemistry of haematology? New clusters of circulating blood cells. Clinical and Translational Dis 2022;2. [DOI: 10.1002/ctd2.19] [Reference Citation Analysis]
25 Kong F, Ye S, Zhong Z, Zhou X, Zhou W, Liu Z, Lan J, Xiong Y, Ye Q. Single-Cell Transcriptome Analysis of Chronic Antibody-Mediated Rejection After Renal Transplantation. Front Immunol 2021;12:767618. [PMID: 35111153 DOI: 10.3389/fimmu.2021.767618] [Reference Citation Analysis]
26 Marx S, Godicelj A, Wucherpfennig KW. A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma. Semin Immunopathol 2022. [PMID: 35505129 DOI: 10.1007/s00281-022-00945-5] [Reference Citation Analysis]
27 Qian X, Zheng H, Xue K, Chen Z, Hu Z, Zhang L, Wan J. Recurrence Risk of Liver Cancer Post-hepatectomy Using Machine Learning and Study of Correlation With Immune Infiltration. Front Genet 2021;12:733654. [PMID: 34956309 DOI: 10.3389/fgene.2021.733654] [Reference Citation Analysis]
28 Fu J, Lei X. Identification of the Immune Subtype of Hepatocellular Carcinoma for the Prediction of Disease-Free Survival Time and Prevention of Recurrence by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data. Front Immunol 2022;13:868325. [DOI: 10.3389/fimmu.2022.868325] [Reference Citation Analysis]
29 Cheng Y, Gong Y, Chen X, Zhang Q, Zhang X, He Y, Pan L, Ni B, Yang F, Xu Y, Zhou L, Yang Y, Chen W. Injectable adhesive hemostatic gel with tumor acidity neutralizer and neutrophil extracellular traps lyase for enhancing adoptive NK cell therapy prevents post-resection recurrence of hepatocellular carcinoma. Biomaterials 2022;284:121506. [PMID: 35390709 DOI: 10.1016/j.biomaterials.2022.121506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lu X, Cui Z, Pan F, Li L, Li L, Liang B, Yang L, Zheng C. Glycemic status affects the severity of coronavirus disease 2019 in patients with diabetes mellitus: an observational study of CT radiological manifestations using an artificial intelligence algorithm. Acta Diabetol 2021;58:575-86. [PMID: 33420614 DOI: 10.1007/s00592-020-01654-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
31 Montella L, Sarno F, Ambrosino A, Facchini S, D'Antò M, Laterza MM, Fasano M, Quarata E, Ranucci RAN, Altucci L, Berretta M, Facchini G. The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma. Cells 2021;10:1909. [PMID: 34440678 DOI: 10.3390/cells10081909] [Reference Citation Analysis]
32 Zhang Y, Li Y, Cao W, Wang F, Xie X, Li Y, Wang X, Guo R, Jiang Z, Guo R. Single-Cell Analysis of Target Antigens of CAR-T Reveals a Potential Landscape of "On-Target, Off-Tumor Toxicity". Front Immunol 2021;12:799206. [PMID: 34975912 DOI: 10.3389/fimmu.2021.799206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
33 Shen J, Shen H, Ke L, Chen J, Dang X, Liu B, Hua Y. Knowledge Mapping of Immunotherapy for Hepatocellular Carcinoma: A Bibliometric Study. Front Immunol 2022;13:815575. [DOI: 10.3389/fimmu.2022.815575] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
34 He W, Hu Y, Chen D, Li Y, Ye D, Zhao Q, Lin L, Shi X, Lu L, Yin Z, He X, Gao Y, Wu Y. Hepatocellular carcinoma-infiltrating γδ T cells are functionally defected and allogenic Vδ2+ γδ T cell can be a promising complement. Clin Transl Med 2022;12:e800. [PMID: 35390227 DOI: 10.1002/ctm2.800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Chen B, Zhu L, Yang S, Su W. Unraveling the Heterogeneity and Ontogeny of Dendritic Cells Using Single-Cell RNA Sequencing. Front Immunol 2021;12:711329. [PMID: 34566965 DOI: 10.3389/fimmu.2021.711329] [Reference Citation Analysis]
36 Fang H, Zeng Y, Zhang L, Chen C, Powell CA, Wang X. Can single cell RNA sequencing reshape the clinical biochemistry of hematology: New clusters of circulating blood cells. Clin Transl Med 2021;11:e671. [PMID: 34898038 DOI: 10.1002/ctm2.671] [Reference Citation Analysis]
37 Gu S, Qian L, Zhang Y, Chen K, Li Y, Wang J, Wang P. Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective. Biochim Biophys Acta Rev Cancer 2021;1876:188632. [PMID: 34626740 DOI: 10.1016/j.bbcan.2021.188632] [Reference Citation Analysis]
38 Gallo O. Risk for COVID-19 infection in patients with tobacco smoke-associated cancers of the upper and lower airway. Eur Arch Otorhinolaryngol 2021;278:2695-702. [PMID: 33216184 DOI: 10.1007/s00405-020-06456-z] [Reference Citation Analysis]
39 Lu Y, Yang A, Quan C, Pan Y, Zhang H, Li Y, Gao C, Lu H, Wang X, Cao P, Chen H, Lu S, Zhou G. A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma. Nat Commun 2022;13:4594. [PMID: 35933472 DOI: 10.1038/s41467-022-32283-3] [Reference Citation Analysis]
40 Santos-de-Frutos K, Djouder N. When dormancy fuels tumour relapse. Commun Biol 2021;4:747. [PMID: 34135460 DOI: 10.1038/s42003-021-02257-0] [Reference Citation Analysis]
41 Chen K, Liu X, Liu W, Wang F, Tian X, Yang Y. Development and validation of prognostic and diagnostic model for pancreatic ductal adenocarcinoma based on scRNA-seq and bulk-seq datasets. Hum Mol Genet 2021:ddab343. [PMID: 34957503 DOI: 10.1093/hmg/ddab343] [Reference Citation Analysis]
42 Zhao X, Liu T, Wang G. Ensemble classification based signature discovery for cancer diagnosis in RNA expression profiles across different platforms. Brief Bioinform 2022:bbac185. [PMID: 35605226 DOI: 10.1093/bib/bbac185] [Reference Citation Analysis]
43 Llovet JM, Castet F, Heikenwalder M, Maini MK, Mazzaferro V, Pinato DJ, Pikarsky E, Zhu AX, Finn RS. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol 2021. [PMID: 34764464 DOI: 10.1038/s41571-021-00573-2] [Reference Citation Analysis]
44 Pasetto A, Lu YC. Single-Cell TCR and Transcriptome Analysis: An Indispensable Tool for Studying T-Cell Biology and Cancer Immunotherapy. Front Immunol 2021;12:689091. [PMID: 34163487 DOI: 10.3389/fimmu.2021.689091] [Reference Citation Analysis]
45 Li L, Fu H, Liu Y. The fibrogenic niche in kidney fibrosis: components and mechanisms. Nat Rev Nephrol 2022. [PMID: 35788561 DOI: 10.1038/s41581-022-00590-z] [Reference Citation Analysis]
46 Peng P, Hu J, Deng HJ, Liu BZ, Fang L, Wang K, Tang N, Huang AL. Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months. Cell Mol Immunol 2021;18:490-1. [PMID: 33420358 DOI: 10.1038/s41423-020-00605-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
47 Song Z, Bao L, Deng W, Liu J, Ren E, Lv Q, Liu M, Qi F, Chen T, Deng R, Li F, Liu Y, Wei Q, Gao H, Yu P, Han Y, Zhao W, Zheng J, Liang X, Yang F, Qin C. Integrated histopathological, lipidomic, and metabolomic profiles reveal mink is a useful animal model to mimic the pathogenicity of severe COVID-19 patients. Signal Transduct Target Ther 2022;7:29. [PMID: 35091528 DOI: 10.1038/s41392-022-00891-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
48 Jiang Z, Zhu H, Wang P, Que W, Zhong L, Li X, Du F. Different subpopulations of regulatory T cells in human autoimmune disease, transplantation, and tumor immunity. MedComm 2022;3. [DOI: 10.1002/mco2.137] [Reference Citation Analysis]
49 Lei Y, Tang R, Xu J, Wang W, Zhang B, Liu J, Yu X, Shi S. Applications of single-cell sequencing in cancer research: progress and perspectives. J Hematol Oncol 2021;14:91. [PMID: 34108022 DOI: 10.1186/s13045-021-01105-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
50 Cai J, Chen Z, Zhang Y, Wang J, Zhang Z, Wu J, Mao J, Zuo X. CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma. Mol Ther Oncolytics 2022;24:755-71. [PMID: 35317519 DOI: 10.1016/j.omto.2022.02.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Ai L, Wang Q, Cheng K. Key genes in the liver fibrosis process are mined based on single-cell transcriptomics. Biochemical and Biophysical Research Communications 2022;598:131-7. [DOI: 10.1016/j.bbrc.2022.01.094] [Reference Citation Analysis]
52 Deng Y, Tan Y, Zhou D, Bai Y, Cao T, Zhong C, Huang W, Ou Y, Guo L, Liu Q, Yin D, Chen L, Luo X, Sun D, Sheng X. Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma. Front Immunol 2022;13:923194. [DOI: 10.3389/fimmu.2022.923194] [Reference Citation Analysis]
53 Yu S, Gao J, Wang H, Liu L, Liu X, Xu Y, Shi J, Guo W, Zhang S. Significance of Liver Zonation in Hepatocellular Carcinoma. Front Cell Dev Biol 2022;10:806408. [DOI: 10.3389/fcell.2022.806408] [Reference Citation Analysis]
54 Arvanitakis K, Koletsa T, Mitroulis I, Germanidis G. Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy. Cancers (Basel) 2022;14:226. [PMID: 35008390 DOI: 10.3390/cancers14010226] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
55 Zeng C, Zhang L, Luo C, Yang C, Huang X, Fan L, Li J, Chen F, Luo Z. A stratification model of hepatocellular carcinoma based on expression profiles of cells in the tumor microenvironment. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09647-5] [Reference Citation Analysis]
56 Sung PS, Park DJ, Roh PR, Mun KD, Cho SW, Lee GW, Jung ES, Lee SH, Jang JW, Bae SH, Choi JY, Choi J, Ahn J, Yoon SK. Intrahepatic inflammatory IgA+PD-L1high monocytes in hepatocellular carcinoma development and immunotherapy. J Immunother Cancer 2022;10:e003618. [PMID: 35577505 DOI: 10.1136/jitc-2021-003618] [Reference Citation Analysis]
57 Shi Y, Zhang Q, Bi H, Lu M, Tan Y, Zou D, Ge L, Chen Z, Liu C, Ci W, Ma L. Decoding the multicellular ecosystem of vena caval tumor thrombus in clear cell renal cell carcinoma by single-cell RNA sequencing. Genome Biol 2022;23:87. [PMID: 35361264 DOI: 10.1186/s13059-022-02651-9] [Reference Citation Analysis]
58 Bae HG, Kim TK, Suk HY, Jung S, Jo DG. White matter and neurological disorders. Arch Pharm Res 2020;43:920-31. [PMID: 32975736 DOI: 10.1007/s12272-020-01270-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
59 Ye D, Liu Y, Li G, Sun B, Peng J, Xu Q. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients. Front Oncol 2021;11:766072. [PMID: 34868990 DOI: 10.3389/fonc.2021.766072] [Reference Citation Analysis]
60 V'kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol 2021;19:155-70. [PMID: 33116300 DOI: 10.1038/s41579-020-00468-6] [Cited by in Crossref: 352] [Cited by in F6Publishing: 307] [Article Influence: 176.0] [Reference Citation Analysis]
61 Fan X, Deng J, Shi T, Wen H, Li J, Liang Z, Lei F, Liu D, Zhang H, Liang Y, Hao X, Wang Z. Design, synthesis and bioactivity study of evodiamine derivatives as multifunctional agents for the treatment of hepatocellular carcinoma. Bioorg Chem 2021;114:105154. [PMID: 34378540 DOI: 10.1016/j.bioorg.2021.105154] [Reference Citation Analysis]
62 Liu Y, Zhang L, Ju X, Wang S, Qie J. Single-Cell Transcriptomic Analysis Reveals Macrophage–Tumor Crosstalk in Hepatocellular Carcinoma. Front Immunol 2022;13:955390. [DOI: 10.3389/fimmu.2022.955390] [Reference Citation Analysis]
63 Li Y, Xu C, Sun B, Zhong F, Cao M, Yang L. Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02574-2] [Reference Citation Analysis]
64 Sas Z, Cendrowicz E, Weinhäuser I, Rygiel TP. Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options. Int J Mol Sci 2022;23:3778. [PMID: 35409139 DOI: 10.3390/ijms23073778] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Chen Z, Huang Y, Hu Z, Zhao M, Li M, Bi G, Zheng Y, Liang J, Lu T, Jiang W, Xu S, Zhan C, Xi J, Wang Q, Tan L. Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma. Clin Transl Med 2021;11:e350. [PMID: 33783985 DOI: 10.1002/ctm2.350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Daher-Nashif S, Al-Anany R, Ali M, Erradi K, Farag E, Abdallah AM, Emara MM. COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity. Arch Virol 2022. [PMID: 35723757 DOI: 10.1007/s00705-022-05495-7] [Reference Citation Analysis]
67 Bárcena-Varela M, Lujambio A. Dissecting Early Relapse in Liver Cancer, One Cell at a Time. Hepatology 2021;74:2891-3. [PMID: 33998693 DOI: 10.1002/hep.31903] [Reference Citation Analysis]
68 Zhou L, Yu KH, Wong TL, Zhang Z, Chan CH, Loong JH, Che N, Yu HJ, Tan KV, Tong M, Ngan ES, Ho JW, Ma S. Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression. Gut 2021:gutjnl-2021-324321. [PMID: 34588223 DOI: 10.1136/gutjnl-2021-324321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
69 Chen Z, Zhao M, Liang J, Hu Z, Huang Y, Li M, Pang Y, Lu T, Sui Q, Zhan C, Lin M, Guo W, Wang Q, Tan L. Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma. EBioMedicine 2021;69:103459. [PMID: 34192657 DOI: 10.1016/j.ebiom.2021.103459] [Reference Citation Analysis]
70 Mercurio I, Tragni V, Busto F, De Grassi A, Pierri CL. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies. Cell Mol Life Sci 2021;78:1501-22. [PMID: 32623480 DOI: 10.1007/s00018-020-03580-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 14.5] [Reference Citation Analysis]
71 Foerster F, Gairing SJ, Ilyas SI, Galle PR. Emerging immunotherapy for HCC: A guide for hepatologists. Hepatology 2022;75:1604-26. [PMID: 35253934 DOI: 10.1002/hep.32447] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
72 Wu H, Zhu JQ, Xu XF, Xing H, Wang MD, Liang L, Li C, Jia HD, Shen F, Huang DS, Yang T. Biointerfacing Antagonizing T-Cell Inhibitory Nanoparticles Potentiate Hepatocellular Carcinoma Checkpoint Blockade Therapy. Small 2021;:e2105237. [PMID: 34791793 DOI: 10.1002/smll.202105237] [Reference Citation Analysis]
73 Liu Z, Zeng H, Jin K, Yu Y, You R, Zhang H, Liu C, Su X, Yan S, Chang Y, Liu L, Xu L, Xu J, Zhu Y, Wang Z. TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer. Br J Cancer 2022. [PMID: 35039625 DOI: 10.1038/s41416-022-01703-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Deczkowska A, David E, Ramadori P, Pfister D, Safran M, At The B, Giladi A, Jaitin DA, Barboy O, Cohen M, Yofe I, Gur C, Shlomi-Loubaton S, Henri S, Suhail Y, Qiu M, Kam S, Hermon H, Lahat E, Ben Yakov G, Cohen-Ezra O, Davidov Y, Likhter M, Goitein D, Roth S, Weber A, Malissen B, Weiner A, Ben-Ari Z, Heikenwälder M, Elinav E, Amit I. XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis. Nat Med 2021;27:1043-54. [PMID: 34017133 DOI: 10.1038/s41591-021-01344-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
75 Li X, Li S, Wu B, Xu Q, Teng D, Yang T, Sun Y, Zhao Y, Li T, Liu D, Yang S, Gong W, Cai J. Landscape of Immune Cells Heterogeneity in Liver Transplantation by Single-Cell RNA Sequencing Analysis. Front Immunol 2022;13:890019. [PMID: 35619708 DOI: 10.3389/fimmu.2022.890019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Luo S, Liang C, Zhang Q, Zhang P. Iridium photosensitizer constructed liposomes with hypoxia-activated prodrug to destrust hepatocellular carcinoma. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.07.009] [Reference Citation Analysis]
77 Tang L. Multiomics sequencing goes spatial. Nat Methods 2021;18:31. [PMID: 33408400 DOI: 10.1038/s41592-020-01043-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Martins F, Santos I, da Cruz E Silva OAB, Tambaro S, Rebelo S. The role of the integral type II transmembrane protein BRI2 in health and disease. Cell Mol Life Sci 2021;78:6807-22. [PMID: 34480585 DOI: 10.1007/s00018-021-03932-5] [Reference Citation Analysis]
79 Gramantieri L, Giovannini C, Suzzi F, Leoni I, Fornari F. Hepatic Cancer Stem Cells: Molecular Mechanisms, Therapeutic Implications, and Circulating Biomarkers. Cancers (Basel) 2021;13:4550. [PMID: 34572776 DOI: 10.3390/cancers13184550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Yu S, Li X, Zhang J, Wu S. Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer. Front Immunol 2021;12:709493. [PMID: 34539641 DOI: 10.3389/fimmu.2021.709493] [Reference Citation Analysis]
81 Zhang S, Xiao X, Zhu X, Chen X, Zhang X, Xiang J, Xu R, Shao Z, Bai J, Xun Y, Jiang Y, Chen Z, Xia X, Jiang H, Ma S. Dysregulated Immune and Metabolic Microenvironment Is Associated with the Post-Operative Relapse in Stage I Non-Small Cell Lung Cancer. Cancers 2022;14:3061. [DOI: 10.3390/cancers14133061] [Reference Citation Analysis]
82 Peng YL, Xiong LB, Zhou ZH, Ning K, Li Z, Wu ZS, Deng MH, Wei WS, Wang N, Zou XP, He ZS, Huang JW, Luo JH, Liu JY, Jia N, Cao Y, Han H, Guo SJ, Dong P, Yu CP, Zhou FJ, Zhang ZL. Single-cell transcriptomics reveals a low CD8+ T cell infiltrating state mediated by fibroblasts in recurrent renal cell carcinoma. J Immunother Cancer 2022;10:e004206. [PMID: 35121646 DOI: 10.1136/jitc-2021-004206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Bai Y, Chen D, Cheng C, Li Z, Chi H, Zhang Y, Zhang X, Tang S, Zhao Q, Ang B, Zhang Y. Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing. Front Immunol 2022;13:950536. [DOI: 10.3389/fimmu.2022.950536] [Reference Citation Analysis]
84 Tian B, Li Q. Single-Cell Sequencing and Its Applications in Liver Cancer. Front Oncol 2022;12:857037. [DOI: 10.3389/fonc.2022.857037] [Reference Citation Analysis]
85 Zhang C, Lei L, Yang X, Ma K, Zheng H, Su Y, Jiao A, Wang X, Liu H, Zou Y, Shi L, Zhou X, Sun C, Hou Y, Xiao Z, Zhang L, Zhang B. Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice. J Immunother Cancer 2021;9:e002809. [PMID: 34642245 DOI: 10.1136/jitc-2021-002809] [Reference Citation Analysis]
86 Zhan T, Gao X, Wang G, Li F, Shen J, Lu C, Xu L, Li Y, Zhang J. Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma. Front Oncol 2021;11:626663. [PMID: 34336642 DOI: 10.3389/fonc.2021.626663] [Reference Citation Analysis]
87 Liu S, Tang Q, Huang J, Zhan M, Zhao W, Yang X, Li Y, Qiu L, Zhang F, Lu L, He X. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data. Aging (Albany NY) 2021;13:11257-80. [PMID: 33820866 DOI: 10.18632/aging.202811] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Liu J, Qu S, Zhang T, Gao Y, Shi H, Song K, Chen W, Yin W. Applications of Single-Cell Omics in Tumor Immunology. Front Immunol 2021;12:697412. [PMID: 34177965 DOI: 10.3389/fimmu.2021.697412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
89 Yan T, Qiu W, Weng H, Fan Y, Zhou G, Yang Z. Single-Cell Transcriptomic Analysis of Ecosystems in Papillary Thyroid Carcinoma Progression. Front Endocrinol (Lausanne) 2021;12:729565. [PMID: 34790166 DOI: 10.3389/fendo.2021.729565] [Reference Citation Analysis]
90 Wang T, Dai L, Shen S, Yang Y, Yang M, Yang X, Qiu Y, Wang W. Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm. Front Immunol 2022;13:843408. [DOI: 10.3389/fimmu.2022.843408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Braud VM, Meghraoui-kheddar A, Elaldi R, Petti L, Germain C, Anjuère F. LLT1-CD161 Interaction in Cancer: Promises and Challenges. Front Immunol 2022;13:847576. [DOI: 10.3389/fimmu.2022.847576] [Reference Citation Analysis]
92 Temraz S, Nasr R, Mukherji D, Kreidieh F, Shamseddine A. Liquid Biopsy Derived Circulating Tumor Cells and Circulating Tumor DNA as Novel Biomarkers in Hepatocellular Carcinoma. Expert Rev Mol Diagn 2022. [PMID: 35758097 DOI: 10.1080/14737159.2022.2094706] [Reference Citation Analysis]
93 Llovet JM, Pinyol R, Kelley RK, El-Khoueiry A, Reeves HL, Wang XW, Gores GJ, Villanueva A. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. Nat Cancer 2022;3:386-401. [PMID: 35484418 DOI: 10.1038/s43018-022-00357-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
94 Aliya S, Lee H, Alhammadi M, Umapathi R, Huh YS. An Overview on Single-Cell Technology for Hepatocellular Carcinoma Diagnosis. Int J Mol Sci 2022;23:1402. [PMID: 35163329 DOI: 10.3390/ijms23031402] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]